Ospedale San Bortolo

Running trials

• Recruiting

  Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  NCT07504458· Phase 3· Source

• Not yet recruiting

  A multicenter, multicohort, phase 2 platform trial to personalize second-line treatment intensity and targeting in HR-positive, HER2-negative metastatic breast cancer through an integrated liquid biopsy algorithm.

  2025-523460-21-00· Phase 2· Source

• Recruiting

  A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

  NCT07203768· Source

• Recruiting

  MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The MITO 31 translational study.

  NCT04091204· Phase 2· Source

• Recruiting

  Pericardiotomy in Cardiac Surgery

  NCT06486636· Source

• Recruiting

  Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

  NCT06533813· Source

• Recruiting

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  NCT06459024· Source

• Recruiting

  The ReTAVI Prospective Observational Registry

  NCT05601453· Source

• Active, not recruiting

  Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

  NCT05501873· Source

• Active, not recruiting

  Cenobamate in Adults With Focal-Onset Seizures

  NCT05859854· Source

• Recruiting

  Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

  NCT06506084· Source

• Active, not recruiting

  Efficacy study of osimertinib in treatment-naïve patients with EGFR mutant NSCLC according to TP53 mutational status (TEMPLE-2)

  2024-517424-18-00· Phase 4· Source

• Active, not recruiting

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· Phase 3· Source

• Enrolling by invitation

  A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

  NCT04574076· Source

• Recruiting

  Metformin versus Tolvaptan in adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD): a phase 3a, independent, multi-centre, 2 parallel arms randomized controlled trial

  NCT03764605· Phase 3· Source

• Completed

  IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

  NCT02967289· Phase 3· Source

• Active, not recruiting

  Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

  NCT01761968· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms3 recruiting
• Acute myeloid leukemia2 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Haemophilia1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Polycystic kidney disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  LOW-PV Continuation

  NCT06752941· Source

• Recruiting

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Source

• Completed

  A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

  NCT01827605· Phase 3· Source

• Completed

  Indolent Non Follicular Lymphomas Prognostic Project

  NCT02904577· Source

Trial sites

• Azienda ULSS 8 "Berica" - Ospedale San Bortolo2 trials
• Azienda ULSS 8 Berica - Ospedale San Bortolo, Divisione di Ematologia2 trials
• Divisione di Ematologia, Ospedale San Bortolo1 trial
• Divisione Ematologia, Ospedale San Bortolo2 trials
• Oncologia di Vicenza - Ospedale San Bortolo0 trials
• Ospedale San Bortolo5 trials
• Ospedale San Bortolo de Vicenza1 trial
• Ospedale San Bortolo di Vicenza6 trials
• Ospedale San Bortolo, Divisione di Ematologia0 trials
• Ospedale San Bortolo, Vicenza1 trial
• San Bortolo Hospital1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Atopic dermatitis (eczema)17 works · 0 trials
• Chronic myeloid leukaemia5 works · 0 trials
• Mantle cell lymphoma5 works · 0 trials